Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06626334 · ClinicalTrials.gov registry record · NA
Blue Light as an Anti-inflammatory and Analgesic Strategy in Thoracic Trauma
A NA study of Pain, Acute and Rib Fractures, sponsored by Rebecca E Kotcher, MD.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT06626334 is a NA study of Pain, Acute and Rib Fractures that is actively recruiting participants, run by Rebecca E Kotcher, MD. The registered enrollment target is 75 participants, below the 99-participant average among 31 other Pain, Acute trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06626334, a NA study of Pain, Acute and Rib Fractures, is actively recruiting participants, sponsored by Rebecca E Kotcher, MD.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The main goal of this clinical trial is to learn if light therapy improves pain and inflammation in adults with painful rib fractures. The main question it aims to answer is: \- Does bright blue light therapy in addition to standard pain treatments improve pain with breathing in adults with painful rib fractures? Researchers will compare participants who receive bright blue light therapy to participants who receive white light therapy and participants who receive only usual lighting conditions to look for differences in their pain control. In addition to their assigned light treatment, all participants will receive standard pain control treatments. Participants will be assigned randomly to one of three groups: one-third will be assigned to bright blue light therapy, one-third will be assigned to bright white light therapy, and one-third will be assigned to usual light only. They will receive their assigned light treatment for 4 hours during the morning/early afternoon for up to 3 days while they are in the hospital. On each day they receive the light treatment and on the day after their final light treatment: * They will be asked twice to rate their pain at rest and with taking a deep breath. * They will be tested to confirm that they are not experiencing delirium, or confusion related to being in the hospital. * Blood samples will be collected to look for changes in inflammation and the circadian clock, the body's natural 24-hour cycle.
Conditions Studied
Interventions
- DEVICE Bright Blue Light
- DEVICE Bright Full-Spectrum (White) Light
- DEVICE Usual Ambient Light
Study Locations (1)
Pennsylvania
- Presbyterian Hospital, University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-10-23 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06626334
The ClinicalTrials.gov registry entry for NCT06626334 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 99-participant average among 31 other Pain, Acute trials with a reported enrollment target (24% lower). The listed sponsor is Rebecca E Kotcher, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain, Acute appearing as the primary indexed condition, and to 3 interventions - of which Bright Blue Light is the first listed.
NCT06626334 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06626334 about?
NCT06626334 is a clinical study titled "Blue Light as an Anti-inflammatory and Analgesic Strategy in Thoracic Trauma". The main goal of this clinical trial is to learn if light therapy improves pain and inflammation in adults with painful rib fractures. The main question it aims to answer is: \- Does bright blue light therapy in addition to standard pain treatments improve pain with breathing in adults with painful...
What is the current status of trial NCT06626334?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2024-10-23. Estimated completion is 2026-08.
What conditions does trial NCT06626334 study?
This clinical trial studies the following conditions: Pain, Acute, Rib Fractures.
What interventions are being tested in trial NCT06626334?
The interventions under investigation include: Bright Blue Light (DEVICE), Bright Full-Spectrum (White) Light (DEVICE), Usual Ambient Light (DEVICE).
Who is sponsoring clinical trial NCT06626334?
This trial is sponsored by Rebecca E Kotcher, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06626334 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TENS Unit for Analgesia During IUD Insertion
RECRUITING · NA
-
Latinx Children and Surgery
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
RCT of Pain Perception With Fast and Slow Tenaculum Application
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Virtual Reality for Pain Management Study
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.